42m
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
BBOT debuted as a publicly traded oncology company developing a differentiated portfolio of three clinical-stage small ...
Recognition at the 2026 Canadian Hydrogen Convention coincides with resource modeling and estimation at the Lawson Discovery, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results